As part of its commercial transformation and ongoing global expansion, Phase Holographic Imaging has appointed Gaia Bioscience Pte Ltd as its new distributor in Singapore and Malaysia. The move is aimed at strengthening PHI’s position in Southeast Asia, a rapidly growing life science hub with new opportunities for research and clinical partnerships. Against this backdrop, we spoke with CEO Patrik Eschricht for a comment.
Read the full interview at biostock.se:
PHI strengthens its presence in Asia through Gaia Bioscience
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/